مرکز منطقه ای اطلاع رساني علوم و فناوري - A randomized, double-blind, placebo-controlled, study of the efficacy and safety of aripiprazole 10, 15 or 20 mg/day for the treatment of patients with acute exacerbations of schizophrenia

Title of article :

A randomized, double-blind, placebo-controlled, study of the efficacy and safety of aripiprazole 10, 15 or 20 mg/day for the treatment of patients with acute exacerbations of schizophrenia

Author/Authors :

Joseph P. McEvoy، نويسنده , , David G. Daniel، نويسنده , , William H. Carson Jr.، نويسنده , , Robert D. McQuade، نويسنده , , Ronald N. Marcus، نويسنده ,

Issue Information :

ماهنامه با شماره پیاپی سال 1995

Pages :

From page :

895

To page :

905

Keywords :

Tolerability , Efficacy , Antipsychotic , Aripiprazole , Schizophrenia

Journal title :

Journal of Psychiatric Research

Serial Year :

1995

Journal title :

Journal of Psychiatric Research

Record number :

157340

Link To Document :

https://search.isc.ac/dl/search/defaultta.aspx?DTC=10&DC=157340